NCCN 2021 Virtual Nursing Program: Advancing Oncology Nursing™

March 17, 2021

The management of cancer is constantly evolving through the introduction of new developments related to cancer treatment and supportive care. This program will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care. 
 
The goal of the NCCN 2021 Virtual Nursing Program: Advancing Oncology Nursing™ is to ensure that oncology nurses, as members of the interprofessional oncology care team, have the knowledge and skills necessary to apply the standards of care to their practice and health care settings for patients with cancer.

Target Audience

This educational program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

The goal of this activity is to ensure that oncology nurses, as members of the interprofessional oncology care team, have the knowledge and skills necessary to apply the standards of care to their practice and health care setting for patients with cancer.

Following this program, participants should be able to:

Overall Learning Objectives
•   Evaluate advances in the management of patients with cancer and key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and apply appropriate treatment and supportive care strategies to optimize patient education and care. 
•   Review issues related to Cultivating Nursing Resilience during a Pandemic; Patient-Reported Outcomes: Assessment and Interventions to Improve Symptom Management; CAR T-Cell Therapy Update; Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer; Navigating Treatment Selection for Patients with Advanced Ovarian Cancer; Current Clinical Challenges in Cancer Pain Management; and, A Practical Approach to Building a Survivorship Program.

Cultivating Nursing Resilience During a Pandemic
•   Discuss the concept of resilience and how it relates to the field of nursing.
•   Identify challenges in cultivating nursing resilience during a pandemic.
•   Discuss techniques that will assist in fostering nursing resilience now and in times of future global health crises.

Patient-Reported Outcomes: Assessment and Interventions to Improve Symptom Management
•   Recognize the challenges of symptom management in patients with cancer.
•   Describe what patient-reported outcomes (PROs) and electronic patient-reported outcomes (ePROs) are, and settings in which they may be used.
•   Discuss how PROs and ePROs may affect cancer care delivery, patient health outcomes, and health care utilization and associated costs.

Evolution of CAR T-Cell Therapy
•   Outline the indications for existing CAR T-cell therapies.
•   Discuss supportive care and logistics needed during CAR T-cell therapy administration.
•   Identify key components of educational materials needed for a successful CAR T-cell therapy program.

Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer
•   Identify the molecular targets for metastatic non-small cell lung cancer (NSCLC).
•   Discuss the recommended targeted agents for metastatic NSCLC.
•   Describe side effects that may occur with targeted therapies.

Navigating Treatment Selection for Patients with Advanced Ovarian Cancer
•   Describe to a patient some of the key factors to consider when selecting among the recommended options for treatment of recurrent/refractory ovarian cancer.
•   Describe considerations when choosing between chemotherapy options versus targeted therapies for treatment of persistent/recurrent disease.
•   Outline for a patient the signs and symptoms associated with recurrent and/or progressive disease versus toxicity from different types of treatment, and explain option for management to improve quality of life.

Current Clinical Challenges in Cancer Pain Management
•   Discuss considerations for prescribing controlled substances during an opioid epidemic.
•   Identify disparities in the prescription of controlled substances and groups that are at risk for inadequate management of cancer pain.
•   Develop methods to reduce disparities and encourage safe prescription of opioids and other controlled substances for the management of cancer pain.

Advancing Survivorship Care through Program Development
•   Describe several different survivorship care models for the long-term follow-up of cancer survivors.
•   Discuss ideas to address special areas of survivorship care including fertility, post allogenic stem cell transplant care, and the transition of survivors of childhood cancer from pediatric to adult survivorship programs.
•   Explain how educational programs for survivors and providers can help promote optimal survivorship care.

Additional information
Supporters: 

This activity is supported by educational grants from:

  • AstraZeneca
  • Genentech, a member of the Roche Group
  • Novartis
  • Pfizer
  • Taiho Oncology, Inc.

This activity is supported by an independent medical education grant from Bristol-Myers Squibb.

This educational activity is supported by an educational grant from GlaxoSmithKline.

Course summary
Available credit: 
  • 5.25 ANCC contact hours
  • 5.25 Participation
Course opens: 
03/16/2021
Course expires: 
08/31/2021
Event starts: 
03/17/2021 - 10:30am
Event ends: 
03/17/2021 - 5:00pm
Cost:
$0.00

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that every 12 months, all faculty, moderators, activity planners and all internal planning staff participating in NCCN continuing education activities are expected to disclose any financial relationships with a commercial interest. In addition, all faculty presentations have been reviewed to ensure education is fair and balanced and that clinical content presented supports safe, effective patient care.  Individuals who do not disclose relevant financial relationships will be disqualified from involvement in the CE activity as a content developer, planner, or presenter.  

Definitions  

NCCN continuing education considers financial relationships to create a conflict of interest when an individual has both a financial relationship with a commercial interest and the opportunity to affect continuing education content about the products or services of a commercial interest with which he/she has a financial relationship. 
NCCN continuing education considers relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. NCCN does not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship.  

Faculty Disclaimers 

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery. 

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling. 

Faculty Disclosures 

The faculty listed below discloses no relevant financial relationships: 

Jessie Holland, MSN, RN, OCN
Diana McMahon, MSN, RN, OCN
Erin M. McMenamin, PhD, CRNP
Rachael L. Schmidt, DNP, APRN, AOCNP
Emily A. Skotte, MSN, APRN, ACNP-BC 
Lauren M. Sullivan, MSN, RN, AGCNS-BC, OCN, BMTCN

The faculty listed below discloses the following relevant financial relationships: 

Paula Anastasia, RN, MN, AOCN 
Merck & Co., Inc.: Nursing Advisory Board 

NCCN Staff Disclosures 

The NCCN Activity Planning staff listed below discloses no relevant financial relationships: 

Mike Abrams; Melissa Esplen; Mark A. Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Lisa Perfidio, MS; Shannon Ryan, CMP; Kathy Ann Smith, CHCP; Sarah Weinstein 

The NCCN Clinical staff listed below discloses no relevant financial relationships: 

Jennifer L. Burns, BS; Mary A. Dwyer, MS, CGC; Anita M. Engh, PhD; Colleen Erb MSN, RN, AOCNP; Deborah A. Freedman-Cass, PhD; Lisa Gurski, PhD; Miranda Hughes, PhD; Beth Lynn; Nicole R. McMillian, MS, CHES; Angela Motter, PhD; Lenora Pluchino, PhD; Hema Sundar, PhD; Samantha Tamburro, BSN, RN, CPON; Amanda E. Visnick, BSN, RN, OCN 

The NCCN Clinical Staff listed below discloses no relevant financial relationships: 

Ndiya Ogba, PhD (Employed by NCCN until 1/12/21)

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses
NCCN designates this educational activity for a maximum of 5.25 contact hours.

Available Credit

  • 5.25 ANCC contact hours
  • 5.25 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Please log in with the same email address used for program registration.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing